The abstract is read at the publisher; the summary is JClub's.
SALL4 distinguishes tumour from normal tissue in South African colorectal cancer patients with average sensitivity 99.9% and specificity 94.22%, and it is linked to survival.
- Why it matters: African populations are underrepresented in colorectal cancer genomics, limiting understanding of population-specific biology and the ability to build precision oncology tools for South African patients.
- What they did: Bulk RNA sequencing of 32 South African CRC samples identified differentially expressed genes and diagnostic performance metrics, with SALL4 validated using TCGA and Kaplan–Meier survival analysis.
- The result: The multi-omics dataset supports SALL4 as a strong diagnostic and prognostic candidate in this South African cohort, enabling future population-specific biomarker development.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.